These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22741177)

  • 1. [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
    Muller O; Qanadli SD; Waeber B; Wuerzner G
    Rev Med Suisse; 2012 May; 8(343):1159-60, 1162-3. PubMed ID: 22741177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal denervation: new treatment for refractory hypertension?].
    Argacha JF; Van de Borne P
    Rev Med Brux; 2012 Sep; 33(4):292-4. PubMed ID: 23091934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y; Persu A; Staessen JA
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension].
    Volpe M; Agabiti-Rosei E; Ambrosioni E; Cottone S; Cuspidi C; Borghi C; De Luca N; Fallo F; Ferri C; Mancia G; Morganti A; Muiesan ML; Sarzani R; Sechi L; Tocci G; Virdis A;
    G Ital Cardiol (Rome); 2012 Dec; 13(12):846-52. PubMed ID: 23196688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant hypertension.
    Wei FF; Zhang ZY; Huang QF; Yang WY; Staessen JA
    Kardiol Pol; 2018; 76(7):1031-1042. PubMed ID: 29905926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of arterial hypertension: from no treatment to renal denervation.
    Stefanadis CI
    Hellenic J Cardiol; 2015; 56(3):277-8. PubMed ID: 26021256
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endovascular renal nerve ablation as a treatment for resistant hypertension].
    Monge M; Lorthioir A; Bobrie G; Briet M; Plouin PF; Sapoval M; Azizi M
    J Mal Vasc; 2013 Dec; 38(6):367-72. PubMed ID: 24135305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of resistant hypertension with percutaneous renal denervation therapy.
    Ong PJ; Foo D; Ho HH
    Heart; 2012 Dec; 98(23):1754-5. PubMed ID: 22821275
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of resistant hypertension in a multidisciplinary unit of renal denervation: protocol and results.
    Fontenla A; García-Donaire JA; Hernández F; Segura J; Salgado R; Cerezo C; Ruilope LM; Arribas F
    Rev Esp Cardiol (Engl Ed); 2013 May; 66(5):364-70. PubMed ID: 24775818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral renal denervation: is the 'fragmentary' procedure 'disabled'?
    Xiao Y; Zhou S; Liu Q
    Int J Cardiol; 2014; 172(1):e258. PubMed ID: 24447756
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catheter-based treatment of drug-resistant hypertension].
    De Benedetti E
    Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation: unde venis et quo vadis?
    Nähle CP; Düsing R; Schild H
    Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation: results of a single-center cohort study.
    Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP
    Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation: a new therapeutic approach for resistant hypertension.
    Cao L; Fu Q; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(18):3302-8. PubMed ID: 25266531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in catheter-based renal denervation can help the uncontrolled hypertensive patient.
    Morrow T
    Manag Care; 2012 Dec; 21(12):45-6. PubMed ID: 23301350
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renal denervation in the treatment of hypertension].
    Tikkanen I; Lappalainen K
    Duodecim; 2013; 129(8):825-32. PubMed ID: 23720950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive treatment of hypertension : Update 2016].
    Menne J; Wachter R
    Internist (Berl); 2016 Sep; 57(9):871-8. PubMed ID: 27558391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
    Burnier M; Narkiewicz K; Kjeldsen SE; Oparil S
    Blood Press; 2017 Dec; 26(6):319-320. PubMed ID: 28975817
    [No Abstract]   [Full Text] [Related]  

  • 20. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
    Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
    Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.